Novel motif:114: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 15:09, 9 September 2013
name: | motif114_AAACCCGCTC |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0009148 | pyrimidine nucleoside triphosphate biosynthetic process | 5.043476e-10 |
GO:0006183 | GTP biosynthetic process | 7.566706e-10 |
GO:0006228 | UTP biosynthetic process | 7.566706e-10 |
GO:0006165 | nucleoside diphosphate phosphorylation | 7.566706e-10 |
GO:0048103 | somatic stem cell division | 1.115225e-9 |
GO:0006241 | CTP biosynthetic process | 3.794413e-9 |
GO:0043503 | skeletal muscle fiber adaptation | 5.502611e-9 |
GO:0021869 | forebrain ventricular zone progenitor cell division | 9.088836e-9 |
GO:0090304 | nucleic acid metabolic process | 1.853448e-8 |
GO:0010717 | regulation of epithelial to mesenchymal transition | 4.266464e-8 |
GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 5.785732e-8 |
GO:0016070 | RNA metabolic process | 8.260232e-8 |
GO:0050434 | positive regulation of viral transcription | 8.303486e-8 |
GO:0021873 | forebrain neuroblast division | 9.084338e-8 |
GO:0017145 | stem cell division | 1.811902e-7 |
GO:0043923 | positive regulation by host of viral transcription | 2.009256e-7 |
GO:0045063 | T-helper 1 cell differentiation | 3.935831e-7 |
GO:0009147 | pyrimidine nucleoside triphosphate metabolic process | 4.722407e-7 |
GO:0006333 | chromatin assembly or disassembly | 5.646303e-7 |
GO:0006310 | DNA recombination | 5.843875e-7 |
GO:0070670 | response to interleukin-4 | 6.044995e-7 |
GO:0010999 | regulation of eIF2 alpha phosphorylation by heme | 6.050251e-7 |
GO:0009589 | detection of UV | 6.050251e-7 |
GO:0000088 | mitotic prophase | 6.050251e-7 |
GO:0021847 | ventricular zone neuroblast division | 8.475958e-7 |
GO:0035425 | autocrine signaling | 9.238445e-7 |
GO:0071353 | cellular response to interleukin-4 | 1.196672e-6 |
GO:0046782 | regulation of viral transcription | 1.217041e-6 |
GO:0010718 | positive regulation of epithelial to mesenchymal transition | 1.481572e-6 |
GO:0006383 | transcription from RNA polymerase III promoter | 1.843573e-6 |
GO:0006139 | nucleobase-containing compound metabolic process | 2.658640e-6 |
GO:0042797 | tRNA transcription from RNA polymerase III promoter | 2.942823e-6 |
GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter | 2.942823e-6 |
GO:0030223 | neutrophil differentiation | 3.009900e-6 |
GO:0042696 | menarche | 3.070340e-6 |
GO:0060689 | cell differentiation involved in salivary gland development | 3.311960e-6 |
GO:0010770 | positive regulation of cell morphogenesis involved in differentiation | 3.703495e-6 |
GO:0070863 | positive regulation of protein exit from endoplasmic reticulum | 3.830943e-6 |
GO:0009267 | cellular response to starvation | 4.036174e-6 |
GO:0060732 | positive regulation of inositol phosphate biosynthetic process | 4.751971e-6 |
GO:0048524 | positive regulation of viral reproduction | 4.802565e-6 |
GO:0030490 | maturation of SSU-rRNA | 4.983482e-6 |
GO:0000079 | regulation of cyclin-dependent protein kinase activity | 6.435380e-6 |
GO:0042274 | ribosomal small subunit biogenesis | 6.448501e-6 |
GO:0021569 | rhombomere 3 development | 6.464777e-6 |
GO:0031497 | chromatin assembly | 6.681856e-6 |
GO:0009303 | rRNA transcription | 6.957614e-6 |
GO:0006396 | RNA processing | 6.961186e-6 |
GO:0034728 | nucleosome organization | 7.206251e-6 |
GO:0071866 | negative regulation of apoptosis in bone marrow | 7.499162e-6 |
GO:0071864 | positive regulation of cell proliferation in bone marrow | 7.499162e-6 |
GO:0045736 | negative regulation of cyclin-dependent protein kinase activity | 7.540610e-6 |
GO:0001662 | behavioral fear response | 7.635523e-6 |
GO:0021759 | globus pallidus development | 7.766301e-6 |
GO:0001963 | synaptic transmission, dopaminergic | 7.772942e-6 |
GO:0030683 | evasion by virus of host immune response | 8.257824e-6 |
GO:0071895 | odontoblast differentiation | 8.302244e-6 |
GO:0016072 | rRNA metabolic process | 8.525958e-6 |
GO:0032784 | regulation of transcription elongation, DNA-dependent | 9.097997e-6 |
GO:0009132 | nucleoside diphosphate metabolic process | 9.372720e-6 |
GO:0042254 | ribosome biogenesis | 9.724752e-6 |
GO:0033153 | T cell receptor V(D)J recombination | 1.136503e-5 |
GO:0002209 | behavioral defense response | 1.242352e-5 |
GO:0042596 | fear response | 1.258180e-5 |
GO:0031444 | slow-twitch skeletal muscle fiber contraction | 1.315732e-5 |
GO:2000243 | positive regulation of reproductive process | 1.317477e-5 |
GO:0006354 | transcription elongation, DNA-dependent | 1.320310e-5 |
GO:0006353 | transcription termination, DNA-dependent | 1.458904e-5 |
GO:0071105 | response to interleukin-11 | 1.542948e-5 |
GO:0031619 | homologous chromosome orientation involved in meiotic metaphase I plate congression | 1.542948e-5 |
GO:0023035 | CD40 signaling pathway | 1.542948e-5 |
GO:0006517 | protein deglycosylation | 1.819964e-5 |
GO:0010467 | gene expression | 1.848014e-5 |
GO:0006364 | rRNA processing | 1.901056e-5 |
GO:0043501 | skeletal muscle adaptation | 1.937357e-5 |
GO:0042255 | ribosome assembly | 1.970409e-5 |
GO:0030327 | prenylated protein catabolic process | 2.028781e-5 |
GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation | 2.046775e-5 |
GO:0006220 | pyrimidine nucleotide metabolic process | 2.075394e-5 |
GO:0033151 | V(D)J recombination | 2.153488e-5 |
GO:0006261 | DNA-dependent DNA replication | 2.351699e-5 |
GO:0005984 | disaccharide metabolic process | 2.506819e-5 |
GO:0009304 | tRNA transcription | 2.669499e-5 |
GO:0044342 | type B pancreatic cell proliferation | 2.705968e-5 |
GO:0010918 | positive regulation of mitochondrial membrane potential | 2.705968e-5 |
GO:0043921 | modulation by host of viral transcription | 2.745676e-5 |
GO:0060631 | regulation of meiosis I | 2.766317e-5 |
GO:0000710 | meiotic mismatch repair | 2.766317e-5 |
GO:0002562 | somatic diversification of immune receptors via germline recombination within a single locus | 2.776249e-5 |
GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 3.417601e-5 |
GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway | 3.837951e-5 |
GO:0060112 | generation of ovulation cycle rhythm | 4.132193e-5 |
GO:0046755 | non-lytic virus budding | 4.580707e-5 |
GO:0042416 | dopamine biosynthetic process | 4.819180e-5 |
GO:0031669 | cellular response to nutrient levels | 4.822524e-5 |
GO:0071824 | protein-DNA complex subunit organization | 4.910502e-5 |
GO:0005989 | lactose biosynthetic process | 5.074949e-5 |
GO:0034470 | ncRNA processing | 5.379940e-5 |
GO:0006844 | acyl carnitine transport | 5.559165e-5 |
GO:0000738 | DNA catabolic process, exonucleolytic | 5.620375e-5 |
GO:0006351 | transcription, DNA-dependent | 5.971432e-5 |
GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development | 6.116477e-5 |
GO:0003061 | positive regulation of the force of heart contraction by norepinephrine | 6.116477e-5 |
GO:0010836 | negative regulation of protein ADP-ribosylation | 6.116477e-5 |
GO:0061153 | trachea gland development | 6.246491e-5 |
GO:0032696 | negative regulation of interleukin-13 production | 6.631180e-5 |
GO:0060564 | negative regulation of mitotic anaphase-promoting complex activity | 7.072495e-5 |
GO:0033235 | positive regulation of protein sumoylation | 7.135367e-5 |
GO:0021872 | forebrain generation of neurons | 7.465640e-5 |
GO:0001957 | intramembranous ossification | 7.473236e-5 |
GO:0002200 | somatic diversification of immune receptors | 7.546971e-5 |
GO:0045943 | positive regulation of transcription from RNA polymerase I promoter | 7.691215e-5 |
GO:0097039 | protein linear polyubiquitination | 7.822371e-5 |
GO:0016558 | protein import into peroxisome matrix | 8.173541e-5 |
GO:0032774 | RNA biosynthetic process | 8.403106e-5 |
GO:0006515 | misfolded or incompletely synthesized protein catabolic process | 8.871402e-5 |
GO:0014888 | striated muscle adaptation | 9.279806e-5 |
GO:0007339 | binding of sperm to zona pellucida | 9.470322e-5 |
GO:0000724 | double-strand break repair via homologous recombination | 9.772064e-5 |
GO:0070327 | thyroid hormone transport | 1.083939e-4 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 1.156174e-4 |
GO:0010226 | response to lithium ion | 1.235310e-4 |
GO:0042093 | T-helper cell differentiation | 1.238280e-4 |
GO:0006334 | nucleosome assembly | 1.258726e-4 |
GO:0034645 | cellular macromolecule biosynthetic process | 1.269868e-4 |
GO:0009062 | fatty acid catabolic process | 1.274629e-4 |
GO:0009451 | RNA modification | 1.278480e-4 |
GO:0006311 | meiotic gene conversion | 1.319967e-4 |
GO:0045128 | negative regulation of reciprocal meiotic recombination | 1.319967e-4 |
GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure | 1.388641e-4 |
GO:0006284 | base-excision repair | 1.394419e-4 |
GO:0000725 | recombinational repair | 1.397994e-4 |
GO:0019054 | modulation by virus of host cellular process | 1.412198e-4 |
GO:0010520 | regulation of reciprocal meiotic recombination | 1.426129e-4 |
GO:0000028 | ribosomal small subunit assembly | 1.470851e-4 |
GO:0072528 | pyrimidine-containing compound biosynthetic process | 1.536993e-4 |
GO:0060253 | negative regulation of glial cell proliferation | 1.569308e-4 |
GO:0042538 | hyperosmotic salinity response | 1.584018e-4 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 1.643688e-4 |
GO:0044339 | canonical Wnt receptor signaling pathway involved in osteoblast differentiation | 1.659835e-4 |
GO:0001988 | positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure | 1.659835e-4 |
GO:0044338 | canonical Wnt receptor signaling pathway involved in mesenchymal stem cell differentiation | 1.659835e-4 |
GO:0006853 | carnitine shuttle | 1.682936e-4 |
GO:0030157 | pancreatic juice secretion | 1.693288e-4 |
GO:0006972 | hyperosmotic response | 1.882028e-4 |
GO:0006362 | transcription elongation from RNA polymerase I promoter | 1.938884e-4 |
GO:0006012 | galactose metabolic process | 1.947475e-4 |
GO:0042594 | response to starvation | 1.966907e-4 |
GO:0042423 | catecholamine biosynthetic process | 1.983394e-4 |
GO:0060968 | regulation of gene silencing | 2.038849e-4 |
GO:0052312 | modulation of transcription in other organism involved in symbiotic interaction | 2.148731e-4 |
GO:0031123 | RNA 3'-end processing | 2.193190e-4 |
GO:0022613 | ribonucleoprotein complex biogenesis | 2.346675e-4 |
GO:0043949 | regulation of cAMP-mediated signaling | 2.388044e-4 |
GO:0016480 | negative regulation of transcription from RNA polymerase III promoter | 2.394246e-4 |
GO:0071218 | cellular response to misfolded protein | 2.422774e-4 |
GO:0072329 | monocarboxylic acid catabolic process | 2.500252e-4 |
GO:0009059 | macromolecule biosynthetic process | 2.534205e-4 |
GO:0051096 | positive regulation of helicase activity | 2.613494e-4 |
GO:0007099 | centriole replication | 2.613494e-4 |
GO:0021943 | formation of radial glial scaffolds | 2.746294e-4 |
GO:0007127 | meiosis I | 2.770405e-4 |
GO:0051095 | regulation of helicase activity | 2.914334e-4 |
GO:0000729 | DNA double-strand break processing | 2.914334e-4 |
GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis | 2.947650e-4 |
GO:0032714 | negative regulation of interleukin-5 production | 3.013182e-4 |
GO:0032916 | positive regulation of transforming growth factor beta3 production | 3.021670e-4 |
GO:0044258 | intestinal lipid catabolic process | 3.047256e-4 |
GO:0018350 | protein esterification | 3.047256e-4 |
GO:0006583 | melanin biosynthetic process from tyrosine | 3.070825e-4 |
GO:0060346 | bone trabecula formation | 3.164348e-4 |
GO:0000398 | nuclear mRNA splicing, via spliceosome | 3.252174e-4 |
GO:0006363 | termination of RNA polymerase I transcription | 3.291399e-4 |
GO:0061099 | negative regulation of protein tyrosine kinase activity | 3.293995e-4 |
GO:0080009 | mRNA methylation | 3.614190e-4 |
GO:0042747 | circadian sleep/wake cycle, REM sleep | 3.614190e-4 |
GO:0006221 | pyrimidine nucleotide biosynthetic process | 3.785421e-4 |
GO:0034976 | response to endoplasmic reticulum stress | 3.788925e-4 |
GO:0051320 | S phase | 3.808552e-4 |
GO:0048488 | synaptic vesicle endocytosis | 3.844358e-4 |
GO:0006352 | transcription initiation, DNA-dependent | 3.865805e-4 |
GO:0006545 | glycine biosynthetic process | 4.008037e-4 |
GO:0006361 | transcription initiation from RNA polymerase I promoter | 4.037579e-4 |
GO:0045838 | positive regulation of membrane potential | 4.394494e-4 |
GO:0006271 | DNA strand elongation involved in DNA replication | 4.408995e-4 |
GO:0010983 | positive regulation of high-density lipoprotein particle clearance | 4.627776e-4 |
GO:0007501 | mesodermal cell fate specification | 4.653836e-4 |
GO:0006635 | fatty acid beta-oxidation | 4.750129e-4 |
GO:0000375 | RNA splicing, via transesterification reactions | 5.057913e-4 |
GO:0016476 | regulation of embryonic cell shape | 5.187254e-4 |
GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase | 5.261612e-4 |
GO:0065004 | protein-DNA complex assembly | 5.738460e-4 |
GO:0002286 | T cell activation involved in immune response | 5.775935e-4 |
GO:0009220 | pyrimidine ribonucleotide biosynthetic process | 5.875594e-4 |
GO:0046939 | nucleotide phosphorylation | 6.027709e-4 |
GO:2000974 | negative regulation of pro-B cell differentiation | 6.059564e-4 |
GO:0060154 | cellular process regulating host cell cycle in response to virus | 6.179394e-4 |
GO:0019264 | glycine biosynthetic process from serine | 6.182387e-4 |
GO:0070672 | response to interleukin-15 | 6.316721e-4 |
GO:0060828 | regulation of canonical Wnt receptor signaling pathway | 6.373975e-4 |
GO:0048619 | embryonic hindgut morphogenesis | 6.502019e-4 |
GO:0008334 | histone mRNA metabolic process | 6.516131e-4 |
GO:0071312 | cellular response to alkaloid | 6.563270e-4 |
GO:0038003 | opioid receptor signaling pathway | 6.563270e-4 |
GO:0050792 | regulation of viral reproduction | 6.669313e-4 |
GO:0035344 | hypoxanthine transport | 6.713843e-4 |
GO:0035364 | thymine transport | 6.713843e-4 |
GO:0021528 | commissural neuron differentiation in spinal cord | 6.713843e-4 |
GO:0015854 | guanine transport | 6.713843e-4 |
GO:0035036 | sperm-egg recognition | 6.718039e-4 |
GO:0009218 | pyrimidine ribonucleotide metabolic process | 6.987367e-4 |
GO:0071480 | cellular response to gamma radiation | 7.050010e-4 |
GO:0060058 | positive regulation of apoptosis involved in mammary gland involution | 7.079616e-4 |
GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway | 7.099294e-4 |
GO:0043570 | maintenance of DNA repeat elements | 7.128470e-4 |
GO:0042149 | cellular response to glucose starvation | 7.129874e-4 |
GO:0015858 | nucleoside transport | 7.202428e-4 |
GO:0006360 | transcription from RNA polymerase I promoter | 7.748107e-4 |
GO:0033314 | mitotic cell cycle DNA replication checkpoint | 7.807528e-4 |
GO:0071044 | histone mRNA catabolic process | 7.994838e-4 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 8.048859e-4 |
GO:0006288 | base-excision repair, DNA ligation | 8.229275e-4 |
GO:0072229 | metanephric proximal convoluted tubule development | 8.239294e-4 |
GO:0042840 | D-glucuronate catabolic process | 8.239294e-4 |
GO:0045404 | positive regulation of interleukin-4 biosynthetic process | 8.283943e-4 |
GO:0021546 | rhombomere development | 8.594876e-4 |
GO:0034198 | cellular response to amino acid starvation | 8.616954e-4 |
GO:0031591 | wybutosine biosynthetic process | 8.711313e-4 |
GO:0006369 | termination of RNA polymerase II transcription | 8.990858e-4 |
GO:0006359 | regulation of transcription from RNA polymerase III promoter | 9.175313e-4 |
GO:0034641 | cellular nitrogen compound metabolic process | 9.190338e-4 |
GO:0031297 | replication fork processing | 9.354521e-4 |
GO:0090181 | regulation of cholesterol metabolic process | 9.611626e-4 |
GO:0032656 | regulation of interleukin-13 production | 1.035485e-3 |
GO:0090263 | positive regulation of canonical Wnt receptor signaling pathway | 1.050595e-3 |
GO:0033233 | regulation of protein sumoylation | 1.058660e-3 |
GO:0048069 | eye pigmentation | 1.094834e-3 |
GO:0010771 | negative regulation of cell morphogenesis involved in differentiation | 1.117750e-3 |
GO:0006438 | valyl-tRNA aminoacylation | 1.137713e-3 |
GO:0071843 | cellular component biogenesis at cellular level | 1.142829e-3 |
GO:0000154 | rRNA modification | 1.171981e-3 |
GO:0032201 | telomere maintenance via semi-conservative replication | 1.207074e-3 |
GO:0008634 | negative regulation of survival gene product expression | 1.208375e-3 |
GO:0090399 | replicative senescence | 1.210300e-3 |
GO:0034551 | mitochondrial respiratory chain complex III assembly | 1.210772e-3 |
GO:0043181 | vacuolar sequestering | 1.210772e-3 |
GO:0005985 | sucrose metabolic process | 1.210772e-3 |
GO:0000023 | maltose metabolic process | 1.210772e-3 |
GO:0046131 | pyrimidine ribonucleoside metabolic process | 1.226477e-3 |
GO:0034505 | tooth mineralization | 1.247844e-3 |
GO:0006478 | peptidyl-tyrosine sulfation | 1.249197e-3 |
GO:0061084 | negative regulation of protein refolding | 1.255845e-3 |
GO:0007569 | cell aging | 1.283523e-3 |
GO:0042474 | middle ear morphogenesis | 1.293103e-3 |
GO:0070861 | regulation of protein exit from endoplasmic reticulum | 1.296213e-3 |
GO:0034660 | ncRNA metabolic process | 1.309432e-3 |
GO:0044068 | modulation by symbiont of host cellular process | 1.322877e-3 |
GO:0006281 | DNA repair | 1.325268e-3 |
GO:0006301 | postreplication repair | 1.342367e-3 |
GO:0042417 | dopamine metabolic process | 1.373124e-3 |
GO:0040030 | regulation of molecular function, epigenetic | 1.376957e-3 |
GO:0021570 | rhombomere 4 development | 1.376957e-3 |
GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus | 1.470422e-3 |
GO:0021658 | rhombomere 3 morphogenesis | 1.491314e-3 |
GO:0043574 | peroxisomal transport | 1.541320e-3 |
GO:0007168 | receptor guanylyl cyclase signaling pathway | 1.555780e-3 |
GO:0006913 | nucleocytoplasmic transport | 1.607379e-3 |
GO:0010833 | telomere maintenance via telomere lengthening | 1.660816e-3 |
GO:0022616 | DNA strand elongation | 1.720684e-3 |
GO:0045005 | maintenance of fidelity involved in DNA-dependent DNA replication | 1.751901e-3 |
GO:0090042 | tubulin deacetylation | 1.772221e-3 |
GO:0097151 | positive regulation of inhibitory postsynaptic membrane potential | 1.772221e-3 |
GO:0070846 | Hsp90 deacetylation | 1.772221e-3 |
GO:0060209 | estrus | 1.772221e-3 |
GO:0030047 | actin modification | 1.772221e-3 |
GO:0032910 | regulation of transforming growth factor beta3 production | 1.820257e-3 |
GO:0032425 | positive regulation of mismatch repair | 1.839404e-3 |
GO:0001842 | neural fold formation | 1.839404e-3 |
GO:0061360 | optic chiasma development | 1.870736e-3 |
GO:2000597 | positive regulation of optic nerve formation | 1.870736e-3 |
GO:0035799 | ureter maturation | 1.870736e-3 |
GO:0021650 | vestibulocochlear nerve formation | 1.870736e-3 |
GO:0021633 | optic nerve structural organization | 1.870736e-3 |
GO:0032202 | telomere assembly | 1.879526e-3 |
GO:0051169 | nuclear transport | 1.884243e-3 |
GO:0010610 | regulation of mRNA stability involved in response to stress | 1.911710e-3 |
GO:0051725 | protein de-ADP-ribosylation | 1.946868e-3 |
GO:0030902 | hindbrain development | 1.978462e-3 |
GO:0001510 | RNA methylation | 2.004544e-3 |
GO:0048240 | sperm capacitation | 2.018279e-3 |
GO:0016561 | protein import into peroxisome matrix, translocation | 2.028104e-3 |
GO:0045168 | cell-cell signaling involved in cell fate commitment | 2.041622e-3 |
GO:0090035 | positive regulation of cellular chaperone-mediated protein complex assembly | 2.125187e-3 |
GO:0014707 | branchiomeric skeletal muscle development | 2.125187e-3 |
GO:0071899 | negative regulation of estrogen receptor binding | 2.132932e-3 |
GO:0070208 | protein heterotrimerization | 2.152141e-3 |
GO:2000241 | regulation of reproductive process | 2.153437e-3 |
GO:0006376 | mRNA splice site selection | 2.200120e-3 |
GO:0007405 | neuroblast proliferation | 2.238537e-3 |
GO:0060623 | regulation of chromosome condensation | 2.243221e-3 |
GO:0071283 | cellular response to iron(III) ion | 2.243221e-3 |
GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore | 2.243221e-3 |
GO:0046680 | response to DDT | 2.243221e-3 |
GO:0046380 | N-acetylneuraminate biosynthetic process | 2.243221e-3 |
GO:0006356 | regulation of transcription from RNA polymerase I promoter | 2.256113e-3 |
GO:0048625 | myoblast cell fate commitment | 2.258252e-3 |
GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening | 2.284246e-3 |
GO:0000722 | telomere maintenance via recombination | 2.295303e-3 |
GO:0016556 | mRNA modification | 2.301304e-3 |
GO:0015864 | pyrimidine nucleoside transport | 2.306363e-3 |
GO:0034504 | protein localization to nucleus | 2.311998e-3 |
GO:0001982 | baroreceptor response to decreased systemic arterial blood pressure | 2.454689e-3 |
GO:0006584 | catecholamine metabolic process | 2.506904e-3 |
GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain | 2.519726e-3 |
GO:0000185 | activation of MAPKKK activity | 2.535495e-3 |
GO:0021861 | forebrain radial glial cell differentiation | 2.569500e-3 |
GO:0070278 | extracellular matrix constituent secretion | 2.608883e-3 |
GO:0010260 | organ senescence | 2.608883e-3 |
GO:0090005 | negative regulation of establishment of protein localization in plasma membrane | 2.686759e-3 |
GO:0006268 | DNA unwinding involved in replication | 2.711916e-3 |
GO:0034059 | response to anoxia | 2.711916e-3 |
GO:0048305 | immunoglobulin secretion | 2.714797e-3 |
GO:0034224 | cellular response to zinc ion starvation | 2.816747e-3 |
GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity | 2.846501e-3 |
GO:0032674 | regulation of interleukin-5 production | 2.848825e-3 |
GO:0046501 | protoporphyrinogen IX metabolic process | 2.865589e-3 |
GO:0002331 | pre-B cell allelic exclusion | 2.865589e-3 |
GO:0045402 | regulation of interleukin-4 biosynthetic process | 2.942687e-3 |
GO:0009712 | catechol-containing compound metabolic process | 2.966266e-3 |
GO:0043484 | regulation of RNA splicing | 2.979218e-3 |
GO:0051298 | centrosome duplication | 2.982876e-3 |
GO:0010948 | negative regulation of cell cycle process | 3.085779e-3 |
GO:0021986 | habenula development | 3.092769e-3 |
GO:0006659 | phosphatidylserine biosynthetic process | 3.152482e-3 |
GO:0060343 | trabecula formation | 3.154242e-3 |
GO:0031282 | regulation of guanylate cyclase activity | 3.178960e-3 |
GO:0021932 | hindbrain radial glia guided cell migration | 3.201215e-3 |
GO:0043048 | dolichyl monophosphate biosynthetic process | 3.205905e-3 |
GO:0003084 | positive regulation of systemic arterial blood pressure | 3.289162e-3 |
GO:0060406 | positive regulation of penile erection | 3.321154e-3 |
GO:2000465 | regulation of glycogen (starch) synthase activity | 3.345988e-3 |
GO:0006013 | mannose metabolic process | 3.355507e-3 |
GO:0032606 | type I interferon production | 3.430470e-3 |
GO:0031848 | protection from non-homologous end joining at telomere | 3.550225e-3 |
GO:0021612 | facial nerve structural organization | 3.550225e-3 |
GO:0021536 | diencephalon development | 3.570605e-3 |
GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 3.577903e-3 |
GO:0042668 | auditory receptor cell fate determination | 3.632334e-3 |
GO:0010002 | cardioblast differentiation | 3.632334e-3 |
GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway | 3.762536e-3 |
GO:0043388 | positive regulation of DNA binding | 3.864831e-3 |
GO:0090085 | regulation of protein deubiquitination | 3.867338e-3 |
GO:0071174 | mitotic cell cycle spindle checkpoint | 3.868901e-3 |
GO:0030538 | embryonic genitalia morphogenesis | 3.879002e-3 |
GO:0032964 | collagen biosynthetic process | 3.912315e-3 |
GO:0031668 | cellular response to extracellular stimulus | 3.957520e-3 |
GO:0051851 | modification by host of symbiont morphology or physiology | 4.011003e-3 |
GO:0043316 | cytotoxic T cell degranulation | 4.016723e-3 |
GO:0019478 | D-amino acid catabolic process | 4.016723e-3 |
GO:0010986 | positive regulation of lipoprotein particle clearance | 4.016723e-3 |
GO:0010719 | negative regulation of epithelial to mesenchymal transition | 4.087687e-3 |
GO:0030903 | notochord development | 4.108249e-3 |
GO:0032786 | positive regulation of transcription elongation, DNA-dependent | 4.108249e-3 |
GO:2000272 | negative regulation of receptor activity | 4.119758e-3 |
GO:0072661 | protein targeting to plasma membrane | 4.157137e-3 |
GO:0051788 | response to misfolded protein | 4.172742e-3 |
GO:0031125 | rRNA 3'-end processing | 4.312696e-3 |
GO:0043163 | cell envelope organization | 4.312696e-3 |
GO:0021568 | rhombomere 2 development | 4.312696e-3 |
GO:0043588 | skin development | 4.321156e-3 |
GO:0060381 | positive regulation of single-stranded telomeric DNA binding | 4.340214e-3 |
GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 4.343744e-3 |
GO:0021983 | pituitary gland development | 4.391683e-3 |
GO:0031953 | negative regulation of protein autophosphorylation | 4.408346e-3 |
GO:0021535 | cell migration in hindbrain | 4.408346e-3 |
GO:0006625 | protein targeting to peroxisome | 4.430288e-3 |
GO:0051252 | regulation of RNA metabolic process | 4.454170e-3 |
GO:0051726 | regulation of cell cycle | 4.549618e-3 |
GO:0070198 | protein localization to chromosome, telomeric region | 4.553297e-3 |
GO:0033133 | positive regulation of glucokinase activity | 4.622475e-3 |
GO:0035607 | fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development | 4.622475e-3 |
GO:0002693 | positive regulation of cellular extravasation | 4.622475e-3 |
GO:0071333 | cellular response to glucose stimulus | 4.697331e-3 |
GO:0071104 | response to interleukin-9 | 4.816329e-3 |
GO:0035522 | monoubiquitinated histone H2A deubiquitination | 4.816329e-3 |
GO:0032211 | negative regulation of telomere maintenance via telomerase | 4.909810e-3 |
GO:0032075 | positive regulation of nuclease activity | 4.918373e-3 |
GO:0032471 | reduction of endoplasmic reticulum calcium ion concentration | 4.943801e-3 |
GO:0009312 | oligosaccharide biosynthetic process | 5.020215e-3 |
GO:0045839 | negative regulation of mitosis | 5.044100e-3 |
GO:0016574 | histone ubiquitination | 5.047839e-3 |
GO:0050812 | regulation of acyl-CoA biosynthetic process | 5.228579e-3 |
GO:0051622 | negative regulation of norepinephrine uptake | 5.228579e-3 |
GO:0070495 | negative regulation of thrombin receptor signaling pathway | 5.228579e-3 |
GO:0051585 | negative regulation of dopamine uptake | 5.228579e-3 |
GO:0061383 | trabecula morphogenesis | 5.250341e-3 |
GO:0050850 | positive regulation of calcium-mediated signaling | 5.303743e-3 |
GO:0051315 | attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation | 5.318006e-3 |
GO:0005983 | starch catabolic process | 5.318006e-3 |
GO:0010524 | positive regulation of calcium ion transport into cytosol | 5.391779e-3 |
GO:0030901 | midbrain development | 5.447531e-3 |
GO:0043628 | ncRNA 3'-end processing | 5.519664e-3 |
GO:0009912 | auditory receptor cell fate commitment | 5.529556e-3 |
GO:0060384 | innervation | 5.565094e-3 |
GO:0010919 | regulation of inositol phosphate biosynthetic process | 5.565094e-3 |
GO:0015680 | intracellular copper ion transport | 5.566959e-3 |
GO:0021837 | motogenic signaling involved in postnatal olfactory bulb interneuron migration | 5.566959e-3 |
GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 5.572231e-3 |
GO:0035470 | positive regulation of vascular wound healing | 5.575168e-3 |
GO:0045540 | regulation of cholesterol biosynthetic process | 5.634007e-3 |
GO:0060059 | embryonic retina morphogenesis in camera-type eye | 5.652068e-3 |
GO:0072162 | metanephric mesenchymal cell differentiation | 5.653443e-3 |
GO:0021764 | amygdala development | 5.714298e-3 |
GO:0001731 | formation of translation preinitiation complex | 5.714298e-3 |
GO:0043922 | negative regulation by host of viral transcription | 5.757138e-3 |
GO:0031577 | spindle checkpoint | 5.861614e-3 |
GO:0021562 | vestibulocochlear nerve development | 5.862554e-3 |
GO:0007379 | segment specification | 5.867320e-3 |
GO:0072179 | nephric duct formation | 5.924020e-3 |
GO:0002456 | T cell mediated immunity | 5.975124e-3 |
GO:0002293 | alpha-beta T cell differentiation involved in immune response | 6.019164e-3 |
GO:0002691 | regulation of cellular extravasation | 6.100796e-3 |
GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin | 6.309826e-3 |
GO:0090398 | cellular senescence | 6.360924e-3 |
GO:0006298 | mismatch repair | 6.427151e-3 |
GO:0051103 | DNA ligation involved in DNA repair | 6.486059e-3 |
GO:0007144 | female meiosis I | 6.492299e-3 |
GO:2000467 | positive regulation of glycogen (starch) synthase activity | 6.501662e-3 |
GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade | 6.515778e-3 |
GO:0072527 | pyrimidine-containing compound metabolic process | 6.537469e-3 |
GO:0070318 | positive regulation of G0 to G1 transition | 6.550640e-3 |
GO:0045351 | type I interferon biosynthetic process | 6.616576e-3 |
GO:0006477 | protein sulfation | 6.623575e-3 |
GO:2000179 | positive regulation of neural precursor cell proliferation | 6.832001e-3 |
GO:0030111 | regulation of Wnt receptor signaling pathway | 6.955972e-3 |
GO:2000277 | positive regulation of oxidative phosphorylation uncoupler activity | 6.956609e-3 |
GO:0050652 | dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process | 6.956609e-3 |
GO:0021879 | forebrain neuron differentiation | 7.008401e-3 |
GO:0071872 | cellular response to epinephrine stimulus | 7.059472e-3 |
GO:0033120 | positive regulation of RNA splicing | 7.093896e-3 |
GO:0033091 | positive regulation of immature T cell proliferation | 7.093896e-3 |
GO:0009298 | GDP-mannose biosynthetic process | 7.124428e-3 |
GO:0021506 | anterior neuropore closure | 7.177194e-3 |
GO:0003085 | negative regulation of systemic arterial blood pressure | 7.346500e-3 |
GO:0045022 | early endosome to late endosome transport | 7.346500e-3 |
GO:0006337 | nucleosome disassembly | 7.369708e-3 |
GO:0090086 | negative regulation of protein deubiquitination | 7.461870e-3 |
GO:0046416 | D-amino acid metabolic process | 7.461870e-3 |
GO:0031167 | rRNA methylation | 7.520505e-3 |
GO:0061050 | regulation of cell growth involved in cardiac muscle cell development | 7.524517e-3 |
GO:0030302 | deoxynucleotide transport | 7.524517e-3 |
GO:0009142 | nucleoside triphosphate biosynthetic process | 7.527864e-3 |
GO:0014061 | regulation of norepinephrine secretion | 7.618573e-3 |
GO:0060996 | dendritic spine development | 7.618573e-3 |
GO:0009988 | cell-cell recognition | 7.703345e-3 |
GO:0031573 | intra-S DNA damage checkpoint | 7.728682e-3 |
GO:0030579 | ubiquitin-dependent SMAD protein catabolic process | 7.802052e-3 |
GO:0006984 | ER-nucleus signaling pathway | 8.043394e-3 |
GO:0021783 | preganglionic parasympathetic nervous system development | 8.164803e-3 |
GO:0072553 | terminal button organization | 8.251745e-3 |
GO:0042732 | D-xylose metabolic process | 8.251745e-3 |
GO:0002457 | T cell antigen processing and presentation | 8.251745e-3 |
GO:0010477 | response to sulfur dioxide | 8.251745e-3 |
GO:0007281 | germ cell development | 8.281028e-3 |
GO:0033126 | positive regulation of GTP catabolic process | 8.448221e-3 |
GO:0046952 | ketone body catabolic process | 8.588404e-3 |
GO:0061015 | snRNA import into nucleus | 8.633449e-3 |
GO:0018364 | peptidyl-glutamine methylation | 8.633449e-3 |
GO:0009311 | oligosaccharide metabolic process | 8.637818e-3 |
GO:0002268 | follicular dendritic cell differentiation | 8.717241e-3 |
GO:0021557 | oculomotor nerve development | 8.736879e-3 |
GO:0009452 | RNA capping | 8.739358e-3 |
GO:0006807 | nitrogen compound metabolic process | 8.752938e-3 |
GO:0016126 | sterol biosynthetic process | 8.787230e-3 |
GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing | 8.928573e-3 |
GO:0006289 | nucleotide-excision repair | 8.933360e-3 |
GO:0006401 | RNA catabolic process | 9.002016e-3 |
GO:0006308 | DNA catabolic process | 9.026709e-3 |
GO:0032673 | regulation of interleukin-4 production | 9.033872e-3 |
GO:0070316 | regulation of G0 to G1 transition | 9.067511e-3 |
GO:0000084 | S phase of mitotic cell cycle | 9.400129e-3 |
GO:0006397 | mRNA processing | 9.472898e-3 |
GO:0002329 | pre-B cell differentiation | 9.500255e-3 |
GO:0071496 | cellular response to external stimulus | 9.539417e-3 |
GO:0031296 | B cell costimulation | 9.542773e-3 |
GO:0021604 | cranial nerve structural organization | 9.579825e-3 |
GO:0006302 | double-strand break repair | 9.601342e-3 |
GO:0090219 | negative regulation of lipid kinase activity | 9.708371e-3 |
GO:0009231 | riboflavin biosynthetic process | 9.708371e-3 |
GO:0035330 | regulation of hippo signaling cascade | 9.863408e-3 |
GO:0033131 | regulation of glucokinase activity | 9.867496e-3 |
GO:0003099 | positive regulation of the force of heart contraction by chemical signal | 9.939506e-3 |
GO:0071422 | succinate transmembrane transport | 9.946979e-3 |
GO:0019402 | galactitol metabolic process | 9.946979e-3 |
GO:0031124 | mRNA 3'-end processing | 9.951262e-3 |
GO:0048339 | paraxial mesoderm development | 9.955962e-3 |
GO:0006488 | dolichol-linked oligosaccharide biosynthetic process | 9.997873e-3 |
GO:0043966 | histone H3 acetylation | 1.022177e-2 |
GO:0033083 | regulation of immature T cell proliferation | 1.023858e-2 |
GO:0045717 | negative regulation of fatty acid biosynthetic process | 1.030941e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0033523 | histone H2B ubiquitination | 1.767675e-8 |
GO:0008334 | histone mRNA metabolic process | 4.231401e-8 |
GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator | 7.849155e-8 |
GO:0046967 | cytosol to ER transport | 1.308624e-7 |
GO:0019060 | intracellular transport of viral proteins in host cell | 1.308624e-7 |
GO:0006396 | RNA processing | 4.063353e-7 |
GO:0021680 | cerebellar Purkinje cell layer development | 4.777349e-7 |
GO:0072259 | metanephric interstitial cell development | 5.927055e-7 |
GO:0090094 | metanephric cap mesenchymal cell proliferation involved in metanephros development | 5.927055e-7 |
GO:0072208 | metanephric smooth muscle tissue development | 5.927055e-7 |
GO:0072168 | specification of anterior mesonephric tubule identity | 5.927055e-7 |
GO:0072184 | renal vesicle progenitor cell differentiation | 5.927055e-7 |
GO:0072169 | specification of posterior mesonephric tubule identity | 5.927055e-7 |
GO:0072166 | posterior mesonephric tubule development | 6.309501e-7 |
GO:0018924 | mandelate metabolic process | 8.155792e-7 |
GO:0006398 | histone mRNA 3'-end processing | 1.017891e-6 |
GO:0003096 | renal sodium ion transport | 1.098444e-6 |
GO:0032782 | bile acid secretion | 1.098444e-6 |
GO:0002483 | antigen processing and presentation of endogenous peptide antigen | 1.102298e-6 |
GO:0022037 | metencephalon development | 1.274461e-6 |
GO:0021695 | cerebellar cortex development | 1.461039e-6 |
GO:0090005 | negative regulation of establishment of protein localization in plasma membrane | 1.663878e-6 |
GO:0045083 | negative regulation of interleukin-12 biosynthetic process | 4.406580e-6 |
GO:0018158 | protein oxidation | 5.352039e-6 |
GO:0010467 | gene expression | 5.790488e-6 |
GO:0021549 | cerebellum development | 5.824891e-6 |
GO:0051444 | negative regulation of ubiquitin-protein ligase activity | 6.165291e-6 |
GO:0008625 | induction of apoptosis via death domain receptors | 6.762554e-6 |
GO:0051297 | centrosome organization | 7.716917e-6 |
GO:0007052 | mitotic spindle organization | 9.717490e-6 |
GO:0060010 | Sertoli cell fate commitment | 1.199251e-5 |
GO:0046984 | regulation of hemoglobin biosynthetic process | 1.273389e-5 |
GO:2000119 | negative regulation of sodium-dependent phosphate transport | 1.344999e-5 |
GO:0021764 | amygdala development | 1.356696e-5 |
GO:0031397 | negative regulation of protein ubiquitination | 1.686414e-5 |
GO:0043149 | stress fiber assembly | 1.700176e-5 |
GO:0090304 | nucleic acid metabolic process | 1.962269e-5 |
GO:0045653 | negative regulation of megakaryocyte differentiation | 2.515939e-5 |
GO:0048384 | retinoic acid receptor signaling pathway | 2.523819e-5 |
GO:0021702 | cerebellar Purkinje cell differentiation | 2.618986e-5 |
GO:0018364 | peptidyl-glutamine methylation | 2.666874e-5 |
GO:0006930 | substrate-dependent cell migration, cell extension | 2.666874e-5 |
GO:0048535 | lymph node development | 2.865260e-5 |
GO:0016358 | dendrite development | 2.868698e-5 |
GO:0071480 | cellular response to gamma radiation | 3.348560e-5 |
GO:0032416 | negative regulation of sodium:hydrogen antiporter activity | 3.386356e-5 |
GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase | 3.386356e-5 |
GO:0032314 | regulation of Rac GTPase activity | 3.396226e-5 |
GO:0031023 | microtubule organizing center organization | 4.476370e-5 |
GO:2000649 | regulation of sodium ion transmembrane transporter activity | 4.928276e-5 |
GO:0061072 | iris morphogenesis | 4.928276e-5 |
GO:0002268 | follicular dendritic cell differentiation | 4.928276e-5 |
GO:0071777 | positive regulation of cell cycle cytokinesis | 5.181324e-5 |
GO:0085020 | protein K6-linked ubiquitination | 5.927347e-5 |
GO:0006681 | galactosylceramide metabolic process | 6.493894e-5 |
GO:0003218 | cardiac left ventricle formation | 6.553919e-5 |
GO:2000688 | positive regulation of rubidium ion transmembrane transporter activity | 7.356577e-5 |
GO:2000682 | positive regulation of rubidium ion transport | 7.356577e-5 |
GO:0001682 | tRNA 5'-leader removal | 7.356577e-5 |
GO:0016078 | tRNA catabolic process | 7.356577e-5 |
GO:0035826 | rubidium ion transport | 7.356577e-5 |
GO:0046587 | positive regulation of calcium-dependent cell-cell adhesion | 7.377969e-5 |
GO:0015876 | acetyl-CoA transport | 9.010020e-5 |
GO:0072500 | negative regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor | 9.010020e-5 |
GO:0016070 | RNA metabolic process | 1.046783e-4 |
GO:0080164 | regulation of nitric oxide metabolic process | 1.267770e-4 |
GO:0006683 | galactosylceramide catabolic process | 1.267770e-4 |
GO:0090003 | regulation of establishment of protein localization in plasma membrane | 1.271647e-4 |
GO:0035645 | enteric smooth muscle cell differentiation | 1.303827e-4 |
GO:0022616 | DNA strand elongation | 1.303827e-4 |
GO:0007497 | posterior midgut development | 1.303827e-4 |
GO:0032754 | positive regulation of interleukin-5 production | 1.365637e-4 |
GO:0060968 | regulation of gene silencing | 1.400052e-4 |
GO:0010939 | regulation of necrotic cell death | 1.430012e-4 |
GO:0001886 | endothelial cell morphogenesis | 1.441929e-4 |
GO:0071394 | cellular response to testosterone stimulus | 1.513389e-4 |
GO:0046985 | positive regulation of hemoglobin biosynthetic process | 1.608829e-4 |
GO:0043973 | histone H3-K4 acetylation | 1.608829e-4 |
GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery | 1.608829e-4 |
GO:0045630 | positive regulation of T-helper 2 cell differentiation | 1.615874e-4 |
GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I | 1.657344e-4 |
GO:0009215 | purine deoxyribonucleoside triphosphate metabolic process | 1.663834e-4 |
GO:0043687 | post-translational protein modification | 1.725135e-4 |
GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus | 1.939999e-4 |
GO:0007051 | spindle organization | 2.046250e-4 |
GO:0022403 | cell cycle phase | 2.217843e-4 |
GO:2000078 | positive regulation of type B pancreatic cell development | 2.320052e-4 |
GO:0006427 | histidyl-tRNA aminoacylation | 2.347810e-4 |
GO:0060349 | bone morphogenesis | 2.485422e-4 |
GO:0072183 | negative regulation of nephron tubule epithelial cell differentiation | 2.626274e-4 |
GO:0070831 | basement membrane assembly | 2.636190e-4 |
GO:0051967 | negative regulation of synaptic transmission, glutamatergic | 2.767121e-4 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 2.831083e-4 |
GO:0008631 | induction of apoptosis by oxidative stress | 2.928490e-4 |
GO:0090307 | spindle assembly involved in mitosis | 2.931318e-4 |
GO:0033299 | secretion of lysosomal enzymes | 2.939280e-4 |
GO:0006397 | mRNA processing | 2.998277e-4 |
GO:0009452 | RNA capping | 3.296550e-4 |
GO:0072133 | metanephric mesenchyme morphogenesis | 3.453216e-4 |
GO:0008380 | RNA splicing | 3.495295e-4 |
GO:0006364 | rRNA processing | 3.592597e-4 |
GO:0007099 | centriole replication | 3.678537e-4 |
GO:0043523 | regulation of neuron apoptosis | 3.962137e-4 |
GO:0072164 | mesonephric tubule development | 4.012305e-4 |
GO:0045736 | negative regulation of cyclin-dependent protein kinase activity | 4.076735e-4 |
GO:0021697 | cerebellar cortex formation | 4.274680e-4 |
GO:0034635 | glutathione transport | 4.489579e-4 |
GO:2000381 | negative regulation of mesoderm development | 5.006442e-4 |
GO:0006044 | N-acetylglucosamine metabolic process | 5.685144e-4 |
GO:0015739 | sialic acid transport | 5.710437e-4 |
GO:0010669 | epithelial structure maintenance | 5.731302e-4 |
GO:0072162 | metanephric mesenchymal cell differentiation | 5.900805e-4 |
GO:0071711 | basement membrane organization | 5.900805e-4 |
GO:0016072 | rRNA metabolic process | 6.032581e-4 |
GO:0032349 | positive regulation of aldosterone biosynthetic process | 6.221128e-4 |
GO:0030221 | basophil differentiation | 6.221128e-4 |
GO:0030902 | hindbrain development | 6.520134e-4 |
GO:0061032 | visceral serous pericardium development | 6.533525e-4 |
GO:0001885 | endothelial cell development | 6.595459e-4 |
GO:0006677 | glycosylceramide metabolic process | 6.995258e-4 |
GO:0072194 | kidney smooth muscle tissue development | 7.284451e-4 |
GO:0016071 | mRNA metabolic process | 7.388788e-4 |
GO:0060591 | chondroblast differentiation | 7.433203e-4 |
GO:0002118 | aggressive behavior | 7.433203e-4 |
GO:0070079 | histone H4-R3 demethylation | 7.465080e-4 |
GO:0018395 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine | 7.465080e-4 |
GO:0070078 | histone H3-R2 demethylation | 7.465080e-4 |
GO:0034470 | ncRNA processing | 7.608110e-4 |
GO:0060536 | cartilage morphogenesis | 7.770974e-4 |
GO:0071044 | histone mRNA catabolic process | 8.517549e-4 |
GO:0021801 | cerebral cortex radial glia guided migration | 8.561701e-4 |
GO:0030149 | sphingolipid catabolic process | 9.057178e-4 |
GO:0072172 | mesonephric tubule formation | 1.023112e-3 |
GO:0046514 | ceramide catabolic process | 1.047907e-3 |
GO:0002064 | epithelial cell development | 1.085918e-3 |
GO:0007144 | female meiosis I | 1.120034e-3 |
GO:0009200 | deoxyribonucleoside triphosphate metabolic process | 1.123522e-3 |
GO:0000087 | M phase of mitotic cell cycle | 1.145255e-3 |
GO:0060547 | negative regulation of necrotic cell death | 1.151144e-3 |
GO:0007196 | inhibition of adenylate cyclase activity by metabotropic glutamate receptor signaling pathway | 1.172223e-3 |
GO:0060122 | inner ear receptor stereocilium organization | 1.182281e-3 |
GO:0042335 | cuticle development | 1.194889e-3 |
GO:2000768 | positive regulation of nephron tubule epithelial cell differentiation | 1.194889e-3 |
GO:0035846 | oviduct epithelium development | 1.194889e-3 |
GO:0035852 | horizontal cell localization | 1.194889e-3 |
GO:0035849 | nephric duct elongation | 1.194889e-3 |
GO:0035847 | uterine epithelium development | 1.194889e-3 |
GO:0032413 | negative regulation of ion transmembrane transporter activity | 1.212602e-3 |
GO:2000505 | regulation of energy homeostasis | 1.224827e-3 |
GO:0033690 | positive regulation of osteoblast proliferation | 1.224827e-3 |
GO:0031129 | inductive cell-cell signaling | 1.261963e-3 |
GO:0007023 | post-chaperonin tubulin folding pathway | 1.261963e-3 |
GO:0042311 | vasodilation | 1.302212e-3 |
GO:0002209 | behavioral defense response | 1.312702e-3 |
GO:2000253 | positive regulation of feeding behavior | 1.326377e-3 |
GO:2000507 | positive regulation of energy homeostasis | 1.326377e-3 |
GO:0051298 | centrosome duplication | 1.329777e-3 |
GO:0072098 | anterior/posterior pattern specification involved in kidney development | 1.336247e-3 |
GO:0048389 | intermediate mesoderm development | 1.336247e-3 |
GO:0072224 | metanephric glomerulus development | 1.348232e-3 |
GO:0042254 | ribosome biogenesis | 1.392093e-3 |
GO:0060707 | trophoblast giant cell differentiation | 1.395154e-3 |
GO:0072075 | metanephric mesenchyme development | 1.447923e-3 |
GO:0035020 | regulation of Rac protein signal transduction | 1.453138e-3 |
GO:0072182 | regulation of nephron tubule epithelial cell differentiation | 1.491637e-3 |
GO:0021696 | cerebellar cortex morphogenesis | 1.525606e-3 |
GO:0071299 | cellular response to vitamin A | 1.533889e-3 |
GO:0008361 | regulation of cell size | 1.552628e-3 |
GO:0071295 | cellular response to vitamin | 1.556026e-3 |
GO:0021766 | hippocampus development | 1.578068e-3 |
GO:0000027 | ribosomal large subunit assembly | 1.593124e-3 |
GO:0006139 | nucleobase-containing compound metabolic process | 1.636063e-3 |
GO:0035307 | positive regulation of protein dephosphorylation | 1.638178e-3 |
GO:0002092 | positive regulation of receptor internalization | 1.667124e-3 |
GO:0072189 | ureter development | 1.690032e-3 |
GO:0044062 | regulation of excretion | 1.690032e-3 |
GO:0001539 | ciliary or flagellar motility | 1.702198e-3 |
GO:0002678 | positive regulation of chronic inflammatory response | 1.747716e-3 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.785349e-3 |
GO:0016264 | gap junction assembly | 1.785349e-3 |
GO:0001757 | somite specification | 1.785349e-3 |
GO:0071300 | cellular response to retinoic acid | 1.804975e-3 |
GO:0000279 | M phase | 1.824517e-3 |
GO:0071312 | cellular response to alkaloid | 1.849381e-3 |
GO:0006670 | sphingosine metabolic process | 1.849381e-3 |
GO:0035306 | positive regulation of dephosphorylation | 1.849381e-3 |
GO:0003382 | epithelial cell morphogenesis | 1.871306e-3 |
GO:0046477 | glycosylceramide catabolic process | 1.896346e-3 |
GO:0090263 | positive regulation of canonical Wnt receptor signaling pathway | 1.899176e-3 |
GO:0032736 | positive regulation of interleukin-13 production | 1.920320e-3 |
GO:0001662 | behavioral fear response | 1.943928e-3 |
GO:0000079 | regulation of cyclin-dependent protein kinase activity | 1.946287e-3 |
GO:0007043 | cell-cell junction assembly | 1.976385e-3 |
GO:0000278 | mitotic cell cycle | 2.023865e-3 |
GO:0030502 | negative regulation of bone mineralization | 2.026164e-3 |
GO:0030853 | negative regulation of granulocyte differentiation | 2.097114e-3 |
GO:0006613 | cotranslational protein targeting to membrane | 2.099560e-3 |
GO:0022007 | convergent extension involved in neural plate elongation | 2.139536e-3 |
GO:2000171 | negative regulation of dendrite development | 2.139536e-3 |
GO:0051775 | response to redox state | 2.139546e-3 |
GO:0032412 | regulation of ion transmembrane transporter activity | 2.250210e-3 |
GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry | 2.347402e-3 |
GO:0003341 | cilium movement | 2.367873e-3 |
GO:0046092 | deoxycytidine metabolic process | 2.397271e-3 |
GO:0007004 | telomere maintenance via telomerase | 2.397271e-3 |
GO:0001510 | RNA methylation | 2.411193e-3 |
GO:0032911 | negative regulation of transforming growth factor beta1 production | 2.444708e-3 |
GO:0035855 | megakaryocyte development | 2.531249e-3 |
GO:0070168 | negative regulation of biomineral tissue development | 2.559463e-3 |
GO:0021591 | ventricular system development | 2.714428e-3 |
GO:0010842 | retina layer formation | 2.814989e-3 |
GO:0072178 | nephric duct morphogenesis | 2.941422e-3 |
GO:0021819 | layer formation in cerebral cortex | 3.026360e-3 |
GO:0006678 | glucosylceramide metabolic process | 3.026360e-3 |
GO:0060285 | ciliary cell motility | 3.041240e-3 |
GO:0035802 | adrenal cortex formation | 3.041240e-3 |
GO:0060649 | mammary gland bud elongation | 3.051896e-3 |
GO:0060659 | nipple sheath formation | 3.051896e-3 |
GO:0045210 | FasL biosynthetic process | 3.051896e-3 |
GO:0006437 | tyrosyl-tRNA aminoacylation | 3.051896e-3 |
GO:0030421 | defecation | 3.051896e-3 |
GO:0034421 | post-translational protein acetylation | 3.051896e-3 |
GO:0048793 | pronephros development | 3.179256e-3 |
GO:0048278 | vesicle docking | 3.301180e-3 |
GO:0051782 | negative regulation of cell division | 3.353125e-3 |
GO:0046668 | regulation of retinal cell programmed cell death | 3.357093e-3 |
GO:0007501 | mesodermal cell fate specification | 3.357093e-3 |
GO:0060829 | negative regulation of canonical Wnt receptor signaling pathway involved in neural plate anterior/posterior pattern formation | 3.404247e-3 |
GO:0060158 | activation of phospholipase C activity by dopamine receptor signaling pathway | 3.405004e-3 |
GO:0021670 | lateral ventricle development | 3.434893e-3 |
GO:0032410 | negative regulation of transporter activity | 3.472804e-3 |
GO:0021799 | cerebral cortex radially oriented cell migration | 3.472804e-3 |
GO:0048178 | negative regulation of hepatocyte growth factor biosynthetic process | 3.580715e-3 |
GO:0010966 | regulation of phosphate transport | 3.580715e-3 |
GO:0001964 | startle response | 3.591385e-3 |
GO:0002149 | hypochlorous acid biosynthetic process | 3.594369e-3 |
GO:0006260 | DNA replication | 3.620361e-3 |
GO:0018208 | peptidyl-proline modification | 3.827810e-3 |
GO:0051225 | spindle assembly | 3.841517e-3 |
GO:0060119 | inner ear receptor cell development | 3.867006e-3 |
GO:0072177 | mesonephric duct development | 3.938248e-3 |
GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 3.942190e-3 |
GO:0034446 | substrate adhesion-dependent cell spreading | 3.970291e-3 |
GO:0000413 | protein peptidyl-prolyl isomerization | 4.035876e-3 |
GO:0045454 | cell redox homeostasis | 4.054942e-3 |
GO:0072141 | renal interstitial cell development | 4.228773e-3 |
GO:2000104 | negative regulation of DNA-dependent DNA replication | 4.278965e-3 |
GO:0035502 | metanephric ureteric bud development | 4.399226e-3 |
GO:0045769 | negative regulation of asymmetric cell division | 4.399226e-3 |
GO:0007207 | activation of phospholipase C activity by muscarinic acetylcholine receptor signaling pathway | 4.399226e-3 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 4.500716e-3 |
GO:0032229 | negative regulation of synaptic transmission, GABAergic | 4.500716e-3 |
GO:0007143 | female meiosis | 4.500716e-3 |
GO:0034660 | ncRNA metabolic process | 4.515453e-3 |
GO:0032966 | negative regulation of collagen biosynthetic process | 4.573778e-3 |
GO:0003326 | pancreatic A cell fate commitment | 4.573778e-3 |
GO:0003329 | pancreatic PP cell fate commitment | 4.573778e-3 |
GO:0043297 | apical junction assembly | 4.581382e-3 |
GO:0030177 | positive regulation of Wnt receptor signaling pathway | 4.671835e-3 |
GO:0051769 | regulation of nitric-oxide synthase biosynthetic process | 4.702465e-3 |
GO:0072161 | mesenchymal cell differentiation involved in kidney development | 4.805257e-3 |
GO:0048246 | macrophage chemotaxis | 4.805257e-3 |
GO:0006412 | translation | 4.839194e-3 |
GO:0031954 | positive regulation of protein autophosphorylation | 4.850046e-3 |
GO:0072284 | metanephric S-shaped body morphogenesis | 4.906073e-3 |
GO:0051182 | coenzyme transport | 4.906073e-3 |
GO:0072278 | metanephric comma-shaped body morphogenesis | 4.906073e-3 |
GO:0072171 | mesonephric tubule morphogenesis | 5.127305e-3 |
GO:0023021 | termination of signal transduction | 5.201862e-3 |
GO:0071316 | cellular response to nicotine | 5.282113e-3 |
GO:0055062 | phosphate ion homeostasis | 5.542599e-3 |
GO:0006710 | androgen catabolic process | 5.605148e-3 |
GO:0043525 | positive regulation of neuron apoptosis | 5.736119e-3 |
GO:0045446 | endothelial cell differentiation | 6.094683e-3 |
GO:0042747 | circadian sleep/wake cycle, REM sleep | 6.101408e-3 |
GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process | 6.101408e-3 |
GO:0006685 | sphingomyelin catabolic process | 6.101408e-3 |
GO:0051014 | actin filament severing | 6.120679e-3 |
GO:0007067 | mitosis | 6.135956e-3 |
GO:0000082 | G1/S transition of mitotic cell cycle | 6.147207e-3 |
GO:0060059 | embryonic retina morphogenesis in camera-type eye | 6.196604e-3 |
GO:0030222 | eosinophil differentiation | 6.237451e-3 |
GO:0034776 | response to histamine | 6.237451e-3 |
GO:0031120 | snRNA pseudouridine synthesis | 6.237451e-3 |
GO:0010616 | negative regulation of cardiac muscle adaptation | 6.237451e-3 |
GO:0001579 | medium-chain fatty acid transport | 6.237451e-3 |
GO:0006285 | base-excision repair, AP site formation | 6.237451e-3 |
GO:0071985 | multivesicular body sorting pathway | 6.263224e-3 |
GO:0044342 | type B pancreatic cell proliferation | 6.263224e-3 |
GO:0046898 | response to cycloheximide | 6.332676e-3 |
GO:0021533 | cell differentiation in hindbrain | 6.626768e-3 |
GO:0060134 | prepulse inhibition | 6.680931e-3 |
GO:0010667 | negative regulation of cardiac muscle cell apoptosis | 6.759378e-3 |
GO:0003407 | neural retina development | 6.791861e-3 |
GO:0072202 | cell differentiation involved in metanephros development | 6.858813e-3 |
GO:0051301 | cell division | 6.974587e-3 |
GO:0051497 | negative regulation of stress fiber assembly | 7.219748e-3 |
GO:0060350 | endochondral bone morphogenesis | 7.276496e-3 |
GO:0042267 | natural killer cell mediated cytotoxicity | 7.444995e-3 |
GO:0014067 | negative regulation of phosphatidylinositol 3-kinase cascade | 7.452561e-3 |
GO:0042733 | embryonic digit morphogenesis | 7.461598e-3 |
GO:0046125 | pyrimidine deoxyribonucleoside metabolic process | 7.553890e-3 |
GO:0001823 | mesonephros development | 7.603072e-3 |
GO:0032409 | regulation of transporter activity | 7.662658e-3 |
GO:0033631 | cell-cell adhesion mediated by integrin | 7.666303e-3 |
GO:0003158 | endothelium development | 7.692945e-3 |
GO:0033599 | regulation of mammary gland epithelial cell proliferation | 7.857156e-3 |
GO:0006680 | glucosylceramide catabolic process | 7.979074e-3 |
GO:0006401 | RNA catabolic process | 7.995867e-3 |
GO:0003214 | cardiac left ventricle morphogenesis | 8.046605e-3 |
GO:0007379 | segment specification | 8.046605e-3 |
GO:0031670 | cellular response to nutrient | 8.052131e-3 |
GO:0006446 | regulation of translational initiation | 8.285499e-3 |
GO:0060764 | cell-cell signaling involved in mammary gland development | 8.319639e-3 |
GO:0072560 | type B pancreatic cell maturation | 8.319639e-3 |
GO:0048167 | regulation of synaptic plasticity | 8.325629e-3 |
GO:0008347 | glial cell migration | 8.496924e-3 |
GO:0033627 | cell adhesion mediated by integrin | 8.555187e-3 |
GO:0060348 | bone development | 8.689587e-3 |
GO:0022898 | regulation of transmembrane transporter activity | 8.753118e-3 |
GO:0072074 | kidney mesenchyme development | 8.810416e-3 |
GO:0046591 | embryonic leg joint morphogenesis | 8.888108e-3 |
GO:0014745 | negative regulation of muscle adaptation | 8.888108e-3 |
GO:0031282 | regulation of guanylate cyclase activity | 8.888108e-3 |
GO:0021542 | dentate gyrus development | 8.915361e-3 |
GO:0048671 | negative regulation of collateral sprouting | 8.919337e-3 |
GO:0006927 | transformed cell apoptosis | 8.919337e-3 |
GO:0003015 | heart process | 8.981798e-3 |
GO:0072176 | nephric duct development | 9.012157e-3 |
GO:0090185 | negative regulation of kidney development | 9.229282e-3 |
GO:0042503 | tyrosine phosphorylation of Stat3 protein | 9.229282e-3 |
GO:0032415 | regulation of sodium:hydrogen antiporter activity | 9.229282e-3 |
GO:0006857 | oligopeptide transport | 9.236883e-3 |
GO:0003062 | regulation of heart rate by chemical signal | 9.236883e-3 |
GO:0051925 | regulation of calcium ion transport via voltage-gated calcium channel activity | 9.252990e-3 |
GO:0010390 | histone monoubiquitination | 9.320029e-3 |
GO:0060154 | cellular process regulating host cell cycle in response to virus | 9.782637e-3 |
GO:0042775 | mitochondrial ATP synthesis coupled electron transport | 9.782637e-3 |
GO:0032465 | regulation of cytokinesis | 9.978477e-3 |
GO:0007098 | centrosome cycle | 1.000627e-2 |
GO:0070512 | positive regulation of histone H4-K20 methylation | 1.012794e-2 |
GO:2000620 | positive regulation of histone H4-K16 acetylation | 1.012794e-2 |
GO:2000617 | positive regulation of histone H3-K9 acetylation | 1.012794e-2 |
GO:0031619 | homologous chromosome orientation involved in meiotic metaphase I plate congression | 1.012794e-2 |
GO:0031860 | telomeric 3' overhang formation | 1.012794e-2 |
GO:0002882 | positive regulation of chronic inflammatory response to non-antigenic stimulus | 1.012794e-2 |
GO:0009789 | positive regulation of abscisic acid mediated signaling pathway | 1.012794e-2 |
GO:0021587 | cerebellum morphogenesis | 1.023304e-2 |
GO:0071872 | cellular response to epinephrine stimulus | 1.024995e-2 |
GO:0060564 | negative regulation of mitotic anaphase-promoting complex activity | 1.024995e-2 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.025810e-2 |
GO:0048478 | replication fork protection | 1.028963e-2 |
GO:0070625 | zymogen granule exocytosis | 1.028963e-2 |
GO:0006682 | galactosylceramide biosynthetic process | 1.028963e-2 |
GO:0035611 | protein branching point deglutamylation | 1.028963e-2 |
GO:0031284 | positive regulation of guanylate cyclase activity | 1.028963e-2 |
GO:0010918 | positive regulation of mitochondrial membrane potential | 1.028963e-2 |
GO:0001914 | regulation of T cell mediated cytotoxicity | 1.030909e-2 |
GO:0060047 | heart contraction | 1.052940e-2 |
GO:0016073 | snRNA metabolic process | 1.053908e-2 |
GO:0009084 | glutamine family amino acid biosynthetic process | 1.057597e-2 |
GO:0043271 | negative regulation of ion transport | 1.058392e-2 |
GO:0001659 | temperature homeostasis | 1.074363e-2 |
GO:0045075 | regulation of interleukin-12 biosynthetic process | 1.080515e-2 |
GO:0032228 | regulation of synaptic transmission, GABAergic | 1.083405e-2 |
GO:0000281 | cytokinesis after mitosis | 1.094412e-2 |
GO:0035095 | behavioral response to nicotine | 1.101424e-2 |
GO:0032347 | regulation of aldosterone biosynthetic process | 1.101424e-2 |
GO:0034645 | cellular macromolecule biosynthetic process | 1.105471e-2 |
GO:0007212 | dopamine receptor signaling pathway | 1.110720e-2 |
GO:0030033 | microvillus assembly | 1.117071e-2 |
GO:0046115 | guanosine catabolic process | 1.126116e-2 |
GO:0042930 | enterobactin transport | 1.126116e-2 |
GO:0090340 | positive regulation of secretion of lysosomal enzymes | 1.126116e-2 |
GO:0034418 | urate biosynthetic process | 1.126116e-2 |
GO:0090187 | positive regulation of pancreatic juice secretion | 1.126116e-2 |
GO:0090108 | positive regulation of high-density lipoprotein particle assembly | 1.126116e-2 |
GO:0007113 | endomitotic cell cycle | 1.126116e-2 |
GO:0006148 | inosine catabolic process | 1.126116e-2 |
GO:0006149 | deoxyinosine catabolic process | 1.126116e-2 |
GO:0006161 | deoxyguanosine catabolic process | 1.126116e-2 |
GO:0009249 | protein lipoylation | 1.126116e-2 |
GO:0031118 | rRNA pseudouridine synthesis | 1.126116e-2 |
GO:0032467 | positive regulation of cytokinesis | 1.131254e-2 |
GO:0021530 | spinal cord oligodendrocyte cell fate specification | 1.140727e-2 |
GO:0090086 | negative regulation of protein deubiquitination | 1.140727e-2 |
GO:0021761 | limbic system development | 1.144452e-2 |
GO:0002676 | regulation of chronic inflammatory response | 1.146219e-2 |
GO:0021527 | spinal cord association neuron differentiation | 1.175720e-2 |
GO:0071901 | negative regulation of protein serine/threonine kinase activity | 1.199268e-2 |
GO:0021678 | third ventricle development | 1.225391e-2 |
GO:0072180 | mesonephric duct morphogenesis | 1.225391e-2 |
GO:0014826 | vein smooth muscle contraction | 1.225391e-2 |
GO:0010332 | response to gamma radiation | 1.251037e-2 |
GO:0032259 | methylation | 1.263813e-2 |
GO:0030219 | megakaryocyte differentiation | 1.267864e-2 |
GO:0033555 | multicellular organismal response to stress | 1.269426e-2 |
GO:0060743 | epithelial cell maturation involved in prostate gland development | 1.293506e-2 |
GO:0061290 | canonical Wnt receptor signaling pathway involved in metanephric kidney development | 1.293506e-2 |
GO:0030433 | ER-associated protein catabolic process | 1.316544e-2 |
GO:0048285 | organelle fission | 1.323204e-2 |
GO:0042596 | fear response | 1.334364e-2 |
GO:0048496 | maintenance of organ identity | 1.340205e-2 |
GO:0051970 | negative regulation of transmission of nerve impulse | 1.354870e-2 |
GO:0032006 | regulation of TOR signaling cascade | 1.365074e-2 |
GO:0048639 | positive regulation of developmental growth | 1.373354e-2 |
GO:0060319 | primitive erythrocyte differentiation | 1.424011e-2 |
GO:0046479 | glycosphingolipid catabolic process | 1.424011e-2 |
GO:0045292 | nuclear mRNA cis splicing, via spliceosome | 1.424011e-2 |
GO:0001839 | neural plate morphogenesis | 1.430607e-2 |
GO:0032970 | regulation of actin filament-based process | 1.431246e-2 |
GO:0032908 | regulation of transforming growth factor beta1 production | 1.443125e-2 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.454949e-2 |
GO:0031396 | regulation of protein ubiquitination | 1.456829e-2 |
GO:0071635 | negative regulation of transforming growth factor beta production | 1.461821e-2 |
GO:0060266 | negative regulation of respiratory burst involved in inflammatory response | 1.485905e-2 |
GO:0072302 | negative regulation of metanephric glomerular mesangial cell proliferation | 1.485905e-2 |
GO:2001076 | positive regulation of metanephric ureteric bud development | 1.485905e-2 |
GO:0044268 | multicellular organismal protein metabolic process | 1.485905e-2 |
GO:0010960 | magnesium ion homeostasis | 1.485905e-2 |
GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway | 1.485905e-2 |
GO:0007356 | thorax and anterior abdomen determination | 1.485905e-2 |
GO:0006189 | 'de novo' IMP biosynthetic process | 1.485905e-2 |
GO:0072210 | metanephric nephron development | 1.496638e-2 |
GO:0048813 | dendrite morphogenesis | 1.506605e-2 |
GO:0014043 | negative regulation of neuron maturation | 1.518593e-2 |
GO:0070925 | organelle assembly | 1.522830e-2 |
GO:0045988 | negative regulation of striated muscle contraction | 1.524914e-2 |
GO:0033205 | cell cycle cytokinesis | 1.528774e-2 |
GO:0021846 | cell proliferation in forebrain | 1.555623e-2 |
GO:0046519 | sphingoid metabolic process | 1.556077e-2 |
GO:0050968 | detection of chemical stimulus involved in sensory perception of pain | 1.572303e-2 |
GO:0045023 | G0 to G1 transition | 1.572303e-2 |
GO:2000001 | regulation of DNA damage checkpoint | 1.572303e-2 |
GO:0008355 | olfactory learning | 1.572303e-2 |
GO:0019402 | galactitol metabolic process | 1.572303e-2 |
GO:0048260 | positive regulation of receptor-mediated endocytosis | 1.573948e-2 |
GO:0015809 | arginine transport | 1.576878e-2 |
GO:0097012 | response to granulocyte macrophage colony-stimulating factor stimulus | 1.594693e-2 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 1.594693e-2 |
GO:0043401 | steroid hormone mediated signaling pathway | 1.605129e-2 |
GO:0045901 | positive regulation of translational elongation | 1.614015e-2 |
GO:0045905 | positive regulation of translational termination | 1.614015e-2 |
GO:0042508 | tyrosine phosphorylation of Stat1 protein | 1.614015e-2 |
GO:0006452 | translational frameshifting | 1.614015e-2 |
GO:0072498 | embryonic skeletal joint development | 1.615678e-2 |
GO:0090007 | regulation of mitotic anaphase | 1.621094e-2 |
GO:0090399 | replicative senescence | 1.628157e-2 |
GO:0018342 | protein prenylation | 1.635567e-2 |
GO:0046070 | dGTP metabolic process | 1.635567e-2 |
GO:0072190 | ureter urothelium development | 1.645950e-2 |
GO:0060556 | regulation of vitamin D biosynthetic process | 1.645950e-2 |
GO:0021592 | fourth ventricle development | 1.645950e-2 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 1.652615e-2 |
GO:0070830 | tight junction assembly | 1.674136e-2 |
GO:0032753 | positive regulation of interleukin-4 production | 1.674136e-2 |
GO:0015074 | DNA integration | 1.674136e-2 |
GO:0001958 | endochondral ossification | 1.702523e-2 |
GO:0006904 | vesicle docking involved in exocytosis | 1.715593e-2 |
GO:0006672 | ceramide metabolic process | 1.728621e-2 |
GO:0022402 | cell cycle process | 1.763328e-2 |
GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process | 1.771543e-2 |
GO:0017144 | drug metabolic process | 1.773935e-2 |
GO:0002315 | marginal zone B cell differentiation | 1.784784e-2 |
GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 1.811654e-2 |
GO:0000910 | cytokinesis | 1.822171e-2 |
GO:0060044 | negative regulation of cardiac muscle cell proliferation | 1.830071e-2 |
GO:0016574 | histone ubiquitination | 1.833085e-2 |
GO:0034205 | beta-amyloid formation | 1.866275e-2 |
GO:0032065 | cortical protein anchoring | 1.866275e-2 |
GO:0002502 | peptide antigen assembly with MHC class I protein complex | 1.866275e-2 |
GO:0010701 | positive regulation of norepinephrine secretion | 1.866275e-2 |
GO:0061387 | regulation of extent of cell growth | 1.875133e-2 |
GO:0060259 | regulation of feeding behavior | 1.882839e-2 |
GO:0046339 | diacylglycerol metabolic process | 1.882839e-2 |
GO:0040016 | embryonic cleavage | 1.882850e-2 |
GO:0045835 | negative regulation of meiosis | 1.892738e-2 |
GO:0060683 | regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling | 1.897316e-2 |
GO:0046881 | positive regulation of follicle-stimulating hormone secretion | 1.897316e-2 |
GO:0019532 | oxalate transport | 1.897316e-2 |
GO:0015802 | basic amino acid transport | 1.930770e-2 |
GO:0006261 | DNA-dependent DNA replication | 1.937183e-2 |
GO:0072268 | pattern specification involved in metanephros development | 1.963087e-2 |
GO:0032916 | positive regulation of transforming growth factor beta3 production | 1.963087e-2 |
GO:0042036 | negative regulation of cytokine biosynthetic process | 1.971854e-2 |
GO:0018126 | protein hydroxylation | 1.983972e-2 |
GO:0060235 | lens induction in camera-type eye | 1.985349e-2 |
GO:0070373 | negative regulation of ERK1 and ERK2 cascade | 1.991155e-2 |
GO:0031448 | positive regulation of fast-twitch skeletal muscle fiber contraction | 2.012717e-2 |
GO:0030522 | intracellular receptor mediated signaling pathway | 2.018564e-2 |
GO:0019067 | viral assembly, maturation, egress, and release | 2.028855e-2 |
GO:0051438 | regulation of ubiquitin-protein ligase activity | 2.030191e-2 |
GO:0006415 | translational termination | 2.054191e-2 |
GO:0006463 | steroid hormone receptor complex assembly | 2.054191e-2 |
GO:0071636 | positive regulation of transforming growth factor beta production | 2.060018e-2 |
GO:0009059 | macromolecule biosynthetic process | 2.064558e-2 |
GO:0032956 | regulation of actin cytoskeleton organization | 2.081254e-2 |
GO:2000696 | regulation of epithelial cell differentiation involved in kidney development | 2.099292e-2 |
GO:0006184 | GTP catabolic process | 2.103943e-2 |
GO:0009755 | hormone-mediated signaling pathway | 2.111420e-2 |